NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES. Eur. J. Emerg. Mol. Sci. 2024;1(01):69-79. Accessed January 15, 2026. https://parthenonfrontiers.com/index.php/ejems/article/view/31